Tirzepatide 30mg
$50.00
Dual GIP/GLP-1 receptor agonist studied for superior weight management and glycemic control. Clinical data shows among the highest efficacy of any metabolic peptide.
Research & Studies
Research Use Only
For in vitro laboratory research use only. Not for human consumption, medical use, or self-administration. Not evaluated by the FDA. Purchaser confirms they are a qualified researcher and assumes all responsibility for compliance with applicable federal, state, and local laws. This compound may be regulated as a controlled substance or prescription drug in certain jurisdictions.
In Vitro Research Protocol Reference
Research Concentration
2.5–15 mg
Frequency
Once weekly
Administration
Subcutaneous injection
Dual GLP-1/GIP agonist. Published research references gradual concentration escalation protocols.
Tirzepatide 30mg
$50.00
Frequently Bought Together
Bac Water 10ml
$8.00
Injection Bundle
$5.00
CJC-1295 + Ipamorelin 10mg
$45.00